Stay updated on Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This reflects a small update to the documentation or underlying page/versioning system.
    Difference
    0.0%
    Check dated 2026-05-18T03:49:34.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page’s revision label was updated from **Revision: v3.5.2** to **Revision: v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-26T15:38:18.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T14:10:46.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page.
    Difference
    0.0%
    Check dated 2026-03-21T20:16:02.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Deleted the citation for Wei AH et al. on risk stratification of low-dose cytarabine and venetoclax in AML (Blood Advances, 2026).
    Difference
    0.0%
    Check dated 2026-03-14T12:36:04.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Added Revision v3.4.3 and removed Revision v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T13:17:23.000Z thumbnail image

Stay in the know with updates to Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.